Ferguson Wellman Capital Management Inc. Trims Holdings in Zoetis Inc. (NYSE:ZTS)

Ferguson Wellman Capital Management Inc. lowered its holdings in Zoetis Inc. (NYSE:ZTS) by 5.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 15,817 shares of the company’s stock after selling 924 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Zoetis were worth $2,577,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. AMF Tjanstepension AB increased its position in Zoetis by 23.4% during the 3rd quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock valued at $20,594,000 after purchasing an additional 20,001 shares during the period. CWM LLC increased its position in shares of Zoetis by 1.8% during the third quarter. CWM LLC now owns 19,330 shares of the company’s stock valued at $3,777,000 after buying an additional 339 shares during the period. LVW Advisors LLC raised its stake in Zoetis by 11.8% in the third quarter. LVW Advisors LLC now owns 1,470 shares of the company’s stock worth $287,000 after buying an additional 155 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Zoetis by 307.5% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,930 shares of the company’s stock worth $572,000 after buying an additional 2,211 shares during the period. Finally, Valeo Financial Advisors LLC boosted its position in Zoetis by 1.1% during the 3rd quarter. Valeo Financial Advisors LLC now owns 8,028 shares of the company’s stock valued at $1,568,000 after acquiring an additional 91 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. UBS Group assumed coverage on Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price target on the stock. Morgan Stanley dropped their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a report on Wednesday, January 29th. Stifel Nicolaus decreased their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $215.00.

Zoetis Price Performance

Shares of NYSE ZTS opened at $171.37 on Monday. The firm has a market cap of $77.32 billion, a P/E ratio of 32.21, a PEG ratio of 2.77 and a beta of 0.90. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The company has a 50 day moving average of $169.26 and a 200 day moving average of $179.22.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date is Monday, April 21st. Zoetis’s payout ratio is currently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.